chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial complaint was sore arm, but following day felt feverish and developed a rash on the torso. The third day the arm was better but slight rash remained and fourth day it was gone.
Nausea; Fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW1076) via an unspecified route of administration in the right arm on 11Jun2021 at 16:00(at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and sulfonamide allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW1076) via an unspecified route of administration in the right arm on 21May2021 at 16:00(at the age of 64-year-old) as a single dose for COVID-19 immunisation. On 12Jun2021 at 16:00, after 24 hours of vaccination, the patient experienced fever and headache. On 14Jun2021 at 06:00, after 62 hours of vaccination, the patient experienced nausea. Since the vaccination, the patient had not been tested for COVID-19. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events Fever and headache after 24 hours, Stomach and Nausea 62 hours later were not resolved at the time of this report.
arm was sore/arm soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old female patient received bnt162b2 (BNT162B2), administered in arm, administration date 16Apr2021 (Lot number: EW0169) at the age of 59 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered" (2021), described as "arm was sore/arm soreness".  Additional information: It was reported that she had no side effects from the second shot. She wondered if she really got it. Her arm was sore with the first vaccine, that was it. No fever or chills.   No follow-up attempts are possible. No further information is expected.
inj site erythema, induration;the sx last 3 days & were fully resolved as of the reporting date;
Arm soreness to touch and with movement x 3 days, gradually lessening each day. Significant fatigue on day 3 post injection x 1 day.
Pt presented to ER 2 days after receiving flu shot. Complaining of numbness and tingly feeling on left side of face, lips, tongue. Difficulty chewing on left side. Blood work neg. Lyme titer neg. Patient given prednisone and acyclovir. Symptoms: Acute Bells Palsey.
Egg sized/shaped, warm, smooth, red spot below infection site/deltoid. Slightly tender at surface, like very mild sunburn.
Student stated he felt lightheaded and nauseous, ate crackers, water and rested x 15 min. before stating he felt better to go to class.
This is a spontaneous report from a contactable medical assistant reporting on behalf of a physician. A 18-year-old female patient received on 30Jun2016 in the morning (between 9:30AM and 10:30AM) first dose of TRUMENBA, lot number M37314, expiration date 30Apr2017) at 0.5 ml single dose intramuscular in the left arm for immunization. Medical history and concomitant medications were not reported. On 30Jun2016 the patient experienced numbness and tingling in both hands, headache and vomiting 20 minutes after receiving the vaccine. The patient's mother called the office later that day, on 30Jun2016, around 1:30 PM and said that the patient vomited when she tried to drink water (caller stated the mother called back because the patient possibly had gotten worse, but it is unknown exactly). The doctor recommended fluid intake and to return to the office or go to the Emergency Room if the symptoms got worse. The patient did not return to the office or go to the Emergency Room and never called back. The patient did return to the office on 05Jul2016 for a Man2 skin test and even thus the reporter was assuming the patient was fine at that point, the final outcome was unknown.
Moderna COVID-19 Vaccine EUA  Fever of 101 degrees F, Intense Fatigue, painful upper arm on injection side, chills, loss of apatite. Shot was administered in the evening, I woke up with symptoms the next day that progressively got worse into the evening, the following day (2 days post vaccine) I woke up feeling fine with very little soreness at injection site which gradually subsided over the next couple of days.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 10-JUN-2014 the patient was vaccinated with ZOSTAVAX. On an unspecified date in JUN 2014, the patient experienced a red, warm area around the injection site that was "bigger than a silver dollar" was reported as not recovered/not resolved. Additional information has been requested.
I developed acute asthma symptoms, including severe shortness of breath upon any kind of exertion. Also a lingering cough that hasn?t gone away.
4 PM 9/16/2010 flu vaccine given. Middle of night same day patient had fever chills shaking - gone by the morning.
booster; soreness of arm at injection site; some muscle ache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer: Unknown), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "soreness of arm at injection site"; MYALGIA (non-serious), outcome "unknown", described as "some muscle ache".  Additional information: Female patient received the Pfizer Covid vaccine as a booster and experienced soreness of arm at injection site and some muscle ache.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt has swelling on left upper side of body under left arm. Started evening of 7/5.
TDAP GIVEN 4/22/09 IN AFTERNOON. LEFT UPPER ARMS SORE REST OF LAST WEEK. EMPLOYEE DESCRIBED A FIRM LUMP AT INJECTION SITE LAST WEEK.  RED BLOTCHY AREA NOTED ON LEFT UPPER ARMS ON 4/27/07. REDNESS MORE GENERALIZED ALONG UPPER LEFT ARM. PATIENT REPORTS THAT HER ARM IS MORE SORE AND SWOLLEN TODAY WITH SORENESS DOWN TO ELBOW. FIRM TISSUE NOTED ALONG INERIOR LATERAL UPPER LEFT ARM. PATIENT ALSO REPORTS THAT UNDERSIDE OF ARM IS SORE. FURTHER EVALUATED BY C.MCGRATH APN AND PRESCRIBE CIPRO 500 MG BID #14. SCHEDULED FOR RE-EVALUATION BY NP ON 5/1/09
7-8 days after receiving second dose of covid vaccine, patient developed erythema, warmth, and edema to bilateral ankles as well as fever. Consistent with reactive arthritis.
Same day post vax, the pt developed swelling and redness which worsened throughout the night. Left thigh is now double the size of the right thigh and is swollen more toward the the knee. He has used cool compresses and Tylenol. He was prescribed antibiotics for a dx of cellulitis by physician.
Dizziness, nausea, headache. Nausea and dizziness began in a few minutes. Nausea very mild and sporadic thus far. Dizziness/lightheadedness more intense and lasting. Mostly gone after 4 hours. Headache briefly and mildly about 3 hours post injection
Information has been received from a physician concerning a 4 year old male patient with no known allergies and no prior medical history, who at 12 months of age, on approximately 8/17/00, was vaccinated with a dose of varicella virus vaccine live (lot number unknown). The physician reported that the patient now has a viral mediated process which is consistent with herpes zoster infection and was diagnosed with acute retinal necrosis of the left eye. It was noted that the patient had laser surgery as an outpatient, sometime in July 2004. Surgical repair (scar barrier) was performed to prevent further deterioration of his left eye. At the time of the surgery, a tiny bit of fluid was obtained from the anterior eye chamber by the ophthalmologist, who sent the specimen to the eye reference lab and all antibodies for VZV, CMV, and EBV were negative. The patient was treated with oral acyclovir (dose not reported) for approximately two weeks then IV acyclovir (dose and duration not reported), and now the patient is back on oral acyclovir. There was no product quality complaint reported. The acute retinal necrosis did not improve and the patient is not yet recovered. It was noted that the patient has never had breakthrough, but neither has he manifested a serologic response. It was noted that this was tested several times for varicella antibodies when the patient presented with the retinal problem and the result was negative. It was noted that immunologically the patient appears normal. There has not been an etiologic diagnosis, just a very aggressive retinal process. Upon internal review, acute retinal necrosis of the left eye was considered an other important medical event (OMIC). Additional information has bee requested.  Follow up on 09/09/04 states: "Follow-up information was received from a health professional who reported that "2 samples of the vitreous fluid" were PCR negative for VZV and was positive for betaglobin. Upon internal review, acute retinal necrosis of the left eye was considered an other important medical event (OMIC).  Additional information has been requested." Additional follow up information was received from a health professional which indicated that the sample of the left anterior eye chamber fluid (vitreous sample) was obtained on approximately 16AUG2004, sent to the laboratory on 25AUG2004, and arrived in the laboratory on 26AUG2004. It was reported VZV DNA was not amplified and B-globin DNA was amplified.The specimen was adequate and no VZV was identified and therefore was VZV negative.
Patient called the clinic 5 days after the vaccine administration to report a rash on the same arm that the vaccine was administered. Patient reported a white bump at the injection site, and there is a rash travelling down the arm to the fingertips that has some itchiness. Patient was prescribed diphenhydramine, and the reaction cleared.
Shingles (scalp); was prescribed Valtrex but the symptoms of the shingles had started some time previous to this so didn't help too much. I also took Gabapentin and Betamethasone. I had the Shingrix vaccine on 2019/2020. The shingles is still somewhat present in my scalp with itching some 7 months later.
Immediately after receiving vaccine patient got up and walked to mom, fell into her arms. His arm around her neck, stiffened, eyes rolled back, loc x 5 seconds and then woke up and said "I had a bad dream". Vitals stable. Patient laid down for 15-20 minutes. Episode lasted 5 seconds and patient had normal mentation after monitored in office x 1/2 hour and d/c'd home w/ mom.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Additional Details: PATIENT WAS VERY ANXIOUS AFTER FEW MINUTES OF TAKIMG HER PFIZER COVID VACCINE.SHE FELT VERY DIZZY,FLUSHED& LIGHT HEADED & ASKED US TO CALL 911, WHO CAME OVER IN A COUPLE OF MINUTES & TOOK HER,I TRIED CALLING HER TO CHECK ON HER ,BUT WAS NOT ABLE TO REACH HER
8 days following vaccine developed itchy, redness at injection site...newspaper accounts refer to this as Covid Arm.
pt recv vax & 12noon parent took child to ER around 8PM the same day due to swelling, redness, & hardness from inj site to foot of lt leg;crying began around 730PM & was inconsolable;
No adverse event; given the same booster dose as last year; This spontaneous case was reported by a patient family member or friend and describes the occurrence of WRONG PRODUCT ADMINISTERED (given the same booster dose as last year) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2022, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (given the same booster dose as last year). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (given the same booster dose as last year) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant products were reported. No treatment drugs were reported   Reporter did not allow further contact
I had very strong flu like symptoms with diarrhea and severe weakness. Swelling and soreness in arm lasted 1 week....could not raise arm without pain for about 6 days. The most disturbing symptom was pain when breathing in ...this started after a few days but is much better. I went to dr. On 8th day because I was so concerned about my strong reaction. My breathing felt like it did when I started getting pneumonia with Covid in July of 2020...scary. I also got congested in chest at same time. I am not physically sick now except my chest has not returned to being totally normal yet. I am still having some discomfort with some breaths and am now almost 2 weeks out
Body aches, chills, shingles and blisters on my behind. I felt terrible. I never get sick.
23OCT97 c/o muscular aches that PM went to sleep @ 10PM;awakened by wife 11PM;stated felt okay;24OCt97 1230AM wife was awakened by bed shaking pt having sz-non responsive;taken to ER combative & disoriented 1-2hr;afeb;adm to hosp for test;
This spontaneous report was received from a consumer referring to herself a 52 year old female patient with seasonal allergies. On 08-AUG-2016 the patient was vaccinated with ZOSTAVAX 0.65 ml, subcutaneous. Concomitant therapies included CELEXA. On 10-AUG-2016, the patient reported that after receiving ZOSTAVAX, she experienced swelling at the injection site approximately 3 inches in diameter. The patient stated that the injection site was "really red, swollen with some itching". She called the physician but, no treatment was given nor lab diagnostic studies were performed. At the time of the reporting the outcome of the events was not recovered. Additional information has been requested.
covid arm ...red rash about 6 inch in size ..no itching , no pain, no fever, no chills, no headche
Received the shot on Monday morning. Started feeling flu like tiredness in late afternoon. Redness and soreness at sight of injection. Felt flu like fatigue all week long and needed to get by on alternating doses of Advil and Tylenol. By Friday the symptoms seemed to subside. OK after that, but it was a tough week.
Headache, hot flashes, chills,overall body aches, redness in injection area, soreness in injection area, heat in the injection area
Pt developed chest pain on 5/20, 2 days after receiving the vaccination. It persisted and he presented to the ED on 5/21 and was found to have elevated troponins and ST elevation concerning for myocarditis/pericarditis. Symptoms improved with ibprofen.
This spontaneous report was received from a back office lead and refers to a 46 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 30-DEC-2015, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB lot # L038499, expiration date: 26-JUN-2017, 1 ml, intramuscularly, in right deltoid (dose number was not provided). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information have been requested.
Info has been received from a medical assistant concerning a female pt who on 07/23/2002 was vaccinated with the 1st dose of pneumococcal vaccine 23 polyvalent (lot #640744/0994L). The pt was "well" at the time of vaccination. Subsequently, that same day, the pt developed a swollen, red, hot, hard arm and was generally not feeling well. She sought unspecified medical attention and recovered. The reporter expressed a concern with the lot. The records of testing prior to release of this lot have been checked by Compliance and found to be satisfactory. The complies with the standards of the Center for Biologics Evaluation and Research and was released. It was also reported that another pt developed adverse experiences following vaccination with pneumococcal vaccine 23 polyvalent (lot #640744/0994L) (WAES #0208USA00021). Additional info has been requested.
no adverse events; patient was administered an improperly stored VARIVAX; This spontaneous report as received from an office manager refers to a patient of unknown age and gender. On 20-JUL-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot # S028925 exp date 16-SEP-2021) (dose and route not reported) that was reconstituted with a properly stored diluent. There was no data digital issue involved. The temperatures of excursion were 6 °F to 14°F (9.0 F) for a time frame of 1 hour on 17-JUL-2020, 15°F to 46 °F (45.9) for 10 hours and 30 minutes on 17-JUL-2020; - 47 °F to 77 °F (77 F) for 15 hours starting at 10:07 pm on 17-JUL-2020 and 78 °F/26 °C or warmer (79.5 F) for 32 hours starting at 2:52 pm on 18-JUL-2020. There was no previous temperature of excursion. No adverse events were reported.
Noticed a lump on Left arm where she received the vaccine in the afternoon on 10/19 (approximately 24 hours later). This was after she experienced burning pain and she described the area as hot to touch.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. The patients' medical history and concurrent conditions were not reported. On 02-JUN-2016, the patient was vaccinated with first dose of GARDASIL 9 (lot # M003659, expiry date: 20-SEP-2017) on 02-JUN-2016. When patient was visiting unspecified department of health for unspecified reasons, patient received second dose of GARDASIL 9 (lot information was not provided) in series on 06-JUN-2016, slightly earlier than PI schedule (inappropriate schedule of vaccine administered). No adverse effects reported. The outcome of the events was unknown. Additional information has been requested.
Pt administered Immunocompromised dose but is not considered Immunocompromised for DM2 Dx. No adverse symptoms or reactions.
Red hot spot at area of injection, red spot persisted for about 1 week before went away.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05May2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 48 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (COVID-19 VACCINE MODERNA), on 10Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin; "Known allergies: sulfa drugs" (unspecified if ongoing), notes: Known allergies: sulfa drugs; "Cough variant asthma" (unspecified if ongoing); "celiac" (unspecified if ongoing), notes: Other medical history: celiac; "juvenile rheumatoid arthritis" (unspecified if ongoing). Concomitant medication(s) included: OMEPRAZOLE, start date: 01Sep2021. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: COVID 19 Treatment; Unknown results, notes: Rebound of Covid after paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Treatment included paxlovid from 01Jul2022 to 06Jul2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
10-28-20-Severe soreness and pain, arm felt heavy, lifting something became an effort d/t discomfort & pain picking up or getting something above my head. Home Tx: Ibuprofen, cold/warm compress, icy hot and Salonpas analgesic cream. Outcome- temporary relief. 11-18-20 - Dr. prescribed Diclofenac sodium topical gel. Outcome- Ineffective. 11-30-20 - Dr. prescribed Meloxicam and PT 12-04-20 to 01-11-21. Outcome- Pain reduced but ROM still limited. 02-22-21- Steroid injection & PT 03-09-21 to 04-13-21.Outcome- Pain/ROM improved then both came back after a few weeks. 08-18-21- Surgery: Manipulation under Anesthesia; 08-30-21- PT+ongoing. Outcome- Pain/ROM improved significantly.
HARD; INDURATED; HOT TISSUE RIGHT UPPER ARM; TENDER TO TOUCH; LIMITED USE OF ARM
A report was received from a health care professional on 10/24/2003 concerning an unspecified number of vaccinees of unknown demography who received 1 ml of the Fluvirin vaccine on 10/24/2003. The reporter was not aware of any adverse events at the time of report.  There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Parent provided the pharmacy with the wrong date of birth at time of first Covid vaccine. Pfizer vaccine (4m-4y/o) was given for the first dose. Pt came back 2 months later for the 2nd vaccine and provided the pharmacy with another date of birth. Verified and pt is 5y/o and the Pfizer vaccine (5y/o-11y/o) was given for the 2nd dose. No adverse event was stated by the parent.
Significant rash across chest, inner arms, itching in ear canals and eyes. Lasted about three days. No tx.
This spontaneous report as received from a pharmacist refers to a 61 year old female patient. On an unknown date in December 2014 (reported as about two years ago) the patient was vaccinated with ZOSTAVAX (dose, route and frequency were not reported) for vaccination. The reporter reported the patient had "recurrent shingles outbreaks", number of outbreaks, duration and severity not specified, since receiving the vaccine. The outcome of herpes zoster was unknown. The reporter did not provide the causality between the event and the vaccine. Additional information has been requested.